Clinical Trial Update: Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

This is a Phase II trial comparing RAILIRI versus FOLFIRI as second-line treatment in advanced colorectal cancer; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• RAILIRI

Snippet

Sponsor: Fudan University | Conditions: Colorectal Carcinoma | Phase 2 | Status: UNKNOWN